ATAIBeckley Inc Share Price Today: Live Updates & Key Insights
ATAIBeckley Inc share price today is $7.15, up 0.14%. The stock opened at $7.17 against the previous close of $7.17, with an intraday high of $7.19 and low of $7.165.
ATAIBeckley Inc Share Price Chart
ATAIBeckley Inc
ATAIBeckley Inc Share Price Performance
ATAIBeckley Inc Institutional Holdings
ATAIBeckley Inc Market Status
ATAIBeckley Inc Fundamentals
Market Cap 2652.57 M
PB Ratio 13.3694
PE Ratio 0.0
Enterprise Value 2427.51 M
Total Assets 310.54 M
Volume 6965932
ATAIBeckley Inc Company Financials
About ATAIBeckley Inc & investment objective
Company Information AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. The company was formerly known as Atai Beckley N.V. and changed its name to AtaiBeckley Inc. in December 2025. AtaiBeckley Inc. was founded in 2018 and is based in New York, New York.
Organisation Biotechnology
Employees 99
Industry Biotechnology
CEO Dr. Srinivas G. Rao M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ATAIBeckley Inc FAQs
What is the share price of ATAIBeckley Inc today?
The current share price of ATAIBeckley Inc is $7.15.
Can I buy ATAIBeckley Inc shares in India?
Yes, Indian investors can buy ATAIBeckley Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy ATAIBeckley Inc shares in India?
You can easily invest in ATAIBeckley Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ATAIBeckley Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ATAIBeckley Inc.
Can I buy fractional shares of ATAIBeckley Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ATAIBeckley Inc?
ATAIBeckley Inc has a market cap of $2652.57 M.
In which sector does ATAIBeckley Inc belong?
ATAIBeckley Inc operates in the Biotechnology sector.
What documents are required to invest in ATAIBeckley Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of ATAIBeckley Inc?
The PE ratio of ATAIBeckley Inc is N/A and the PB ratio is 13.37.